Troutner D E
Department of Chemistry, University of Missouri, Columbia 65211.
Int J Rad Appl Instrum B. 1987;14(3):171-6. doi: 10.1016/0883-2897(87)90039-0.
There are many radionuclides with a wide range of energies and half-lives available for use as non-sealed radiotherapeutic agents. To date, no single radionuclide has emerged as being clearly superior to all others, in the way that 99mTc predominates in diagnostic imaging. It is unlikely that one will emerge. Instead, if a particular application demands certain decay properties, the radionuclide which will be used will be the one for which appropriate chemistry can be developed and which can be produced and distributed most economically.
